Abstract:The complex impacts of prolonged morphine exposure continue to be a significant focus in the expanding area of addiction studies. This research investigates the effectiveness of a combined treatment using Cabergoline and Mdivi‐1 to counteract the neuroadaptive changes caused by in vitro morphine treatment. The impact of Methadone, Cabergoline, and a combination of Cabergoline and Mdivi‐1 on the cellular and molecular responses associated with Morphine‐induced changes was studied in human Neuroblastoma (SK‐N‐MC) and Glioblastoma (U87‐MG) cell lines that were exposed to prolong Morphine treatment. Cabergoline and Mdivi‐1 combined treatment effectively influenced the molecular alterations associated with neuroadaptation in chronic morphine‐exposed neural cells. This combination therapy normalized autophagy and reduced oxidative stress by enhancing total‐antioxidant capacity, mitigating apoptosis, restoring BDNF expression, and balancing apoptotic elements. Our research outlines morphine's dual role in modulating mitochondrial dynamics via the dysregulation of the autophagy–apoptosis axis. This emphasizes the significant involvement of DRP1 activity in neurological adaptation processes, as well as disturbances in the dopaminergic pathway during in vitro chronic exposure to morphine in neural cells. This study proposes a novel approach by recommending the potential effectiveness of combining Cabergoline and Mdivi‐1 to modulate the neuroadaptations caused by morphine. Additionally, we identified BDNF and PCNA in neural cells as potential neuroprotective markers for assessing the effectiveness of drugs against opioid toxicity, emphasizing the need for further validation. The study uncovers diverse effects observed in pretreated morphine glioblastoma cells under treatment with Cabergoline and methadone. This highlights the potential for new treatments in the DRD2 pathway and underscores the importance of investigating the interplay between autophagy and apoptosis to advance research in managing cancer‐related pain. The study necessitates an in‐depth investigation into the relationship between autophagy and apoptosis, with a specific emphasis on protein interactions and the dynamics of cell signaling.

Chronic morphine application is protective against cell death in primary human neurons.

Prolonged Morphine Application Modulates Bax and Hsp70 Levels in Primary Rat Neurons

Inhibition of SNAP-25 Phosphorylation at Ser187 is Involved in Chronic Morphine-induced Down-regulation of SNARE Complex Formation

Morphine: a protective or destructive role in neurons?

Morphine Epigenomically Regulates Behavior Through Alterations in Histone H3 Lysine 9 Dimethylation in the Nucleus Accumbens

Morphine Protects Against Intracellular Amyloid Toxicity By Inducing Estradiol Release And Upregulation Of Hsp70

Neuronal Apoptosis in Morphine Addiction and Its Molecular Mechanism

Exploring neuroadaptive cellular pathways in chronic morphine exposure: An in‐vitro analysis of cabergoline and Mdivi‐1 co‐treatment effects on the autophagy–apoptosis axis

Neuron apoptosis increases in morphine-dependent rats

Morphine promotes apoptosis in Jurkat cells.

Morphine induces Beclin 1- and ATG5-dependent autophagy in human neuroblastoma SH-SY5Y cells and in the rat hippocampus.

The Neuroprotection of Low-Dose Morphine in Cellular and Animal Models of Parkinson's Disease Through Ameliorating Endoplasmic Reticulum (ER) Stress and Activating Autophagy.

Atg5- And Atg7-Dependent Autophagy In Dopaminergic Neurons Regulates Cellular And Behavioral Responses To Morphine

Chronic Morphine Treatment Switches The Effect Of Dopamine On Excitatory Synaptic Transmission From Inhibition To Excitation In Pyramidal Cells Of The Basolateral Amygdala

The role of caveolin-1 in morphine-induced structural plasticity in primary cultured mouse cerebral cortical neurons.

Glycogen synthase kinase-3 and p38 MAPK are required for opioid-induced microglia apoptosis.

Effects and mechanisms of chronic morphine exposure on extracellular glutamate concentration in C6 cells

Molecular Mechanism of Neuroprotective Effect of Melatonin on Morphine Addiction and Analgesic Tolerance: an Update

Deep proteomics and phosphoproteomics reveal novel biological pathways perturbed by morphine, morphine‐3‐glucuronide and morphine‐6‐glucuronide in human astrocytes

Morphine-Driven m6A Epitranscriptomic Neuroadaptations in Primary Cortical Cultures

Glibenclamide Abolish Cardioprotection of Morphine Preconditioning in Murine Cultured Heart Cells